The Cigna Group vs. Clover Health Investments, Corp
The Cigna Group (CI) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| CI | CLOV | |
|---|---|---|
| Market Cap | $72.51 billion | $2.18 billion |
| Revenue (TTM) | $282.38 billion | $2.48 billion |
| Net Income (TTM) | $6.98 billion | $-18,362,000 |
CI leads on 3 of 3 size & scale factors.
Valuation
| CI | CLOV | |
|---|---|---|
| P/E Ratio | 11.47 | — |
| Price / Book | 1.69 | 5.79 |
| Price / Sales | 0.26 | 0.88 |
CI leads on 2 of 2 valuation factors.
Profitability
| CI | CLOV | |
|---|---|---|
| Net Margin | 2.47% | -0.74% |
| Return on Equity | 16.27% | -4.88% |
CI leads on 2 of 2 profitability factors.
Dividend
| CI | CLOV | |
|---|---|---|
| Dividend Yield | 2.25% | — |
| Payout Ratio | 25.80 | — |
CI and CLOV split the dividend factors evenly.
Risk & Sentiment
| CI | CLOV | |
|---|---|---|
| Short Interest | 1.14% | 2.09% |
CI leads on 1 of 1 risk & sentiment factors.
Dig deeper: CI overview, CI financials, CLOV overview, CLOV financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.